BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang F, Wu Q, Sun S, Bi G, Guo L. Identification of potential diagnostic biomarkers for Parkinson's disease. FEBS Open Bio 2019;9:1460-8. [PMID: 31199560 DOI: 10.1002/2211-5463.12687] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Kishi JY, Liu N, West ER, Sheng K, Jordanides JJ, Serrata M, Cepko CL, Saka SK, Yin P. Light-Seq: light-directed in situ barcoding of biomolecules in fixed cells and tissues for spatially indexed sequencing. Nat Methods 2022. [PMID: 36216958 DOI: 10.1038/s41592-022-01604-1] [Reference Citation Analysis]
2 Semenova EI, Vlasov IN, Partevian SA, Rosinskaya AV, Rybolovlev IN, Slominsky PA, Shadrina MI, Alieva AK. Transcriptome Profiling Reveals Differential Expression of Circadian Behavior Genes in Peripheral Blood of Monozygotic Twins Discordant for Parkinson's Disease. Cells 2022;11:2599. [PMID: 36010675 DOI: 10.3390/cells11162599] [Reference Citation Analysis]
3 Labandeira CM, Pedrosa MA, Quijano A, Valenzuela R, Garrido-Gil P, Sanchez-Andrade M, Suarez-Quintanilla JA, Rodriguez-Perez AI, Labandeira-Garcia JL. Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease. NPJ Parkinsons Dis 2022;8:76. [PMID: 35701430 DOI: 10.1038/s41531-022-00340-9] [Reference Citation Analysis]
4 Augustine J, Jereesh AS. Blood-based gene-expression biomarkers identification for the non-invasive diagnosis of Parkinson's disease using two-layer hybrid feature selection. Gene 2022;823:146366. [PMID: 35202733 DOI: 10.1016/j.gene.2022.146366] [Reference Citation Analysis]
5 Pantaleo E, Monaco A, Amoroso N, Lombardi A, Bellantuono L, Urso D, Lo Giudice C, Picardi E, Tafuri B, Nigro S, Pesole G, Tangaro S, Logroscino G, Bellotti R. A Machine Learning Approach to Parkinson’s Disease Blood Transcriptomics. Genes 2022;13:727. [DOI: 10.3390/genes13050727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ahluwalia K, Ebright B, Chow K, Dave P, Mead A, Poblete R, Louie SG, Asante I. Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development. Metabolites 2022;12:333. [DOI: 10.3390/metabo12040333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hossain MB, Islam MK, Adhikary A, Rahaman A, Islam MZ. Bioinformatics Approach to Identify Significant Biomarkers, Drug Targets Shared Between Parkinson's Disease and Bipolar Disorder: A Pilot Study. Bioinform Biol Insights 2022;16:11779322221079232. [PMID: 35221677 DOI: 10.1177/11779322221079232] [Reference Citation Analysis]
8 Narváez-Bandera I, Suárez-Gómez D, Isaza CE, Cabrera-Ríos M. Multiple Criteria Optimization (MCO): A gene selection deterministic tool in RStudio. PLoS One 2022;17:e0262890. [PMID: 35085348 DOI: 10.1371/journal.pone.0262890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wang K, Lu Y, Morrow DF, Xiao D, Xu C; Alzheimer’s Disease Neuroimaging Initiative. Associations of ARHGAP26 Polymorphisms with Alzheimer's Disease and Cardiovascular Disease. J Mol Neurosci 2022. [PMID: 35171450 DOI: 10.1007/s12031-022-01972-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Duro MV, Ebright B, Yassine HN. Lipids and brain inflammation in APOE4-associated dementia. Curr Opin Lipidol 2022;33:16-24. [PMID: 34907965 DOI: 10.1097/MOL.0000000000000801] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Augustine J, Jereesh AS. An Ensemble Feature Selection Framework for the Early Non-invasive Prediction of Parkinson’s Disease from Imbalanced Microarray Data. Communications in Computer and Information Science 2022. [DOI: 10.1007/978-3-031-12641-3_1] [Reference Citation Analysis]
12 Daniel NH, Aravind A, Thakur P. Are ion channels potential therapeutic targets for Parkinson's disease? Neurotoxicology 2021;87:243-57. [PMID: 34699791 DOI: 10.1016/j.neuro.2021.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Aguila J, Cheng S, Kee N, Cao M, Wang M, Deng Q, Hedlund E. Spatial RNA Sequencing Identifies Robust Markers of Vulnerable and Resistant Human Midbrain Dopamine Neurons and Their Expression in Parkinson's Disease. Front Mol Neurosci 2021;14:699562. [PMID: 34305528 DOI: 10.3389/fnmol.2021.699562] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
14 Karaaslan Z, Kahraman ÖT, Şanlı E, Ergen HA, Ulusoy C, Bilgiç B, Yılmaz V, Tüzün E, Hanağası HA, Küçükali Cİ. Inflammation and regulatory T cell genes are differentially expressed in peripheral blood mononuclear cells of Parkinson's disease patients. Sci Rep 2021;11:2316. [PMID: 33504893 DOI: 10.1038/s41598-021-81961-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
15 Monaco A, Pantaleo E, Amoroso N, Bellantuono L, Lombardi A, Tateo A, Tangaro S, Bellotti R. Identifying potential gene biomarkers for Parkinson's disease through an information entropy based approach. Phys Biol 2020;18:016003. [PMID: 33049726 DOI: 10.1088/1478-3975/abc09a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
16 Zhou S, Zhang D, Guo J, Chen Z, Chen Y, Zhang J. Deficiency of NEAT1 prevented MPP+-induced inflammatory response, oxidative stress and apoptosis in dopaminergic SK-N-SH neuroblastoma cells via miR-1277-5p/ARHGAP26 axis. Brain Res 2021;1750:147156. [PMID: 33069733 DOI: 10.1016/j.brainres.2020.147156] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
17 Falchetti M, Prediger RD, Zanotto-Filho A. Classification algorithms applied to blood-based transcriptome meta-analysis to predict idiopathic Parkinson's disease. Comput Biol Med 2020;124:103925. [PMID: 32889300 DOI: 10.1016/j.compbiomed.2020.103925] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Reyes O, Pérez E, Luque RM, Castaño J, Ventura S. A supervised machine learning-based methodology for analyzing dysregulation in splicing machinery: An application in cancer diagnosis. Artif Intell Med 2020;108:101950. [PMID: 32972670 DOI: 10.1016/j.artmed.2020.101950] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
19 Váradi C. Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms. Biology (Basel) 2020;9:E103. [PMID: 32438686 DOI: 10.3390/biology9050103] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
20 Kidalov MB, Savchenko EV. Methods for early diagnosis of Parkinson’s disease. Aspirantskiy Vestnik Povolzhiya 2020;20:62-67. [DOI: 10.17816/2072-2354.2020.20.1.62-67] [Reference Citation Analysis]
21 Krokidis MG. Identification of biomarkers associated with Parkinson's disease by gene expression profiling studies and bioinformatics analysis. AIMS Neurosci 2019;6:333-45. [PMID: 32341987 DOI: 10.3934/Neuroscience.2019.4.333] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
22 Fan Y, Li J, Yang Q, Gong C, Gao H, Mao Z, Yuan X, Zhu S, Xue Z. Dysregulated Long Non-coding RNAs in Parkinson's Disease Contribute to the Apoptosis of Human Neuroblastoma Cells. Front Neurosci 2019;13:1320. [PMID: 31920490 DOI: 10.3389/fnins.2019.01320] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
23 Sakharkar MK, Kashmir Singh SK, Rajamanickam K, Mohamed Essa M, Yang J, Chidambaram SB. A systems biology approach towards the identification of candidate therapeutic genes and potential biomarkers for Parkinson's disease. PLoS One 2019;14:e0220995. [PMID: 31487305 DOI: 10.1371/journal.pone.0220995] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
24 Aguila J, Cheng S, Kee N, Cao M, Wang M, Deng Q, Hedlund E. Spatial RNA sequencing identifies robust markers of vulnerable and resistant human midbrain dopamine neurons and their expression in Parkinson’s Disease.. [DOI: 10.1101/334417] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]